New Wertheim UF Scripps Scientist Expands Chemists’ Tools
A new scientist joining The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology invents creative and efficient ways to build complex, potentially useful molecules, studying their activity so that compounds found in nature may eventually become useful products, such as medications.
Wertheim UF Scripps Institute Scientists Find Potential Cellular Target for HIV Therapies
Researchers at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology have discovered a protein that appears to play a key role in helping HIV replicate in human immune cells, providing more clues about how cellular machinery allows the virus to create new copies of itself.
Genetic Cause of Als and Dementia Repaired by RNA-Targeting Strategy Developed at UF Scripps
Scientists at UF Scripps Biomedical Research have developed a potential medicine for a leading cause of ALS and dementia that works by eliminating disease-causing segments of RNA. The compound restored the health of neurons in the lab and rescued mice with the disease.
Jupiter Scientist Courtney Miller Named BioFlorida’s Entrepreneur of the Year
Praising her ongoing passion for developing a new class of treatments for cancer and addiction, Florida’s biotechnology industry organization, BioFlorida, has awarded its 2022 Weaver H. Gaines Entrepreneur of the Year award to Courtney Miller, Ph.D., director of academic affairs and a professor at UF Scripps Biomedical Research in Jupiter, Florida.
Wertheim Foundation provides lead gift of $100 million to UF Scripps
The University of Florida today announced that the Dr. Herbert and Nicole Wertheim Family Foundation has provided $100 million — the largest gift from an individual donor in university history — to elevate the stature of UF Scripps as one of the world’s leading forces in biomedical research and to advance the leading-edge work of faculty at the campus in Jupiter, Florida.
UF Scripps Study: Opioid Drug Tolerance Develops From Interplay of Key Gene and Cholesterol
UF Scripps Biomedical Research scientists have discovered a key gene that is shedding light on how people develop tolerance to pain-relievers over time, a problem that raises risk of addiction and overdose.
Biochemist Studying How Cells Defend Against Viruses Joins UF Scripps Biomedical Research
A new scientist joining UF Scripps Biomedical Research, James M. Burke, Ph.D., is exploring how our innate immune system protects us from viruses — including the pandemic coronavirus — and how viruses evade these defenses.
Chemist Who Explores Cells’ Protein Interactions With Light To Join UF Scripps Biomedical Research
Promising new drugs sometimes fail when they reach clinical trials despite strong early data. A new scientist joining UF Scripps Biomedical Research aims to address this problem with new chemistry tools that map interactions within cells.
UF Scripps Scientists To Receive $15 Million To Help Fight Current and Future Pandemics
Multiple scientists from UF Scripps Biomedical Research will join a massive federal effort to develop antiviral drugs to treat the pandemic coronavirus and other viral threats.
UF Scripps Researcher’s Drug-Discovery Method Shows Promise Against Aggressive Breast Cancer
UF Scripps Biomedical Research scientist Matthew Disney, Ph.D. has found yet another groundbreaking approach to a problem that has long vexed scientists: How to cure diseases by targeting key RNA. Until now, RNA has been an elusive target for drug discovery. Discoveries made by Disney and his collaborators have rewritten that dogma.
